Clinical efficacy of basic fibroblast growth factor on pressure ulcers: Case-control pairing study using a new evaluation method

Wound Repair and Regeneration

Volumn 19, Issue 5, 2011, Pages 542-551

  Ohura, Takehiko ^a,b   Nakajo, Toshio ^c,d   Moriguchi, Takahiko ^e   Oka, Hiroaki ^f   Tachi, Masahiro ^g   Ohura Jr , Norihiko ^h   Nogami, Reiko ⁱ   Murayama, Shizuko ^j  

^a HOKKAIDO UNIVERSITY   (Japan)

^b Wound Healing Research Center (Kojin kai)   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d Aoba Hospital (Aobakai)   (Japan)

^e KAWASAKI UNIVERSITY OF MEDICAL WELFARE   (Japan)

^f Kasaoka Daiichi Hospital   (Japan)

^g TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h KYORIN UNIVERSITY   (Japan)

ⁱ National Sanatorium Kikuchi Keifuen   (Japan)

^j Aomori Chuo Gakuin University   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DECUBITUS; DRUG EFFICACY; EPITHELIZATION; FEMALE; GRANULATION TISSUE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; WOUND FLUID; WOUND HEALING;

ADMINISTRATION, INHALATION; ADMINISTRATION, TOPICAL; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; MALE; PRESSURE ULCER; WOUND HEALING;

EID: 80052781501     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2011.00726.x     Document Type: Article

References (35)

1. Bennett NT, Schultz GS,. Growth factors and wound healing: biochemical properties. Am J Surg 1993; 165: 728-37.
2. Winter GD,. Formation of the scab and the rate of epithelization of superficial wounds in the skin of the young domestic pig. Nature 1962; 193: 293-4.
3. Martin P,. Wound healing/aiming for perfect skin regeneration. Science 1997; 276: 75-81. (Pubitemid 27161246)
4. Andersen L, Fejerskov O,. Ultrastructure of initial epithelial cell migration in palatal wounds of guinea pigs. J Ultrastruct Res 1974; 48: 313-24.
5. Field CK, Kerstein MD,. Overview of wound healing in a moist environment. Am J Surg 1994; 167 (1A Suppl.): 2S-6S.
6. Pierce GF,. Role of platelet-derived growth factor in wound healing. J Cell Biochem 1991; 45: 319-26.
7. Pierce GF, Tarpley JE, Yanagihara D, Mustoe TA, Fox GM, Thomason A,. Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Neovessel and matrix formation and cessation of repair. Am J Pathol 1992; 140: 1375-88.
8. Nanney LB,. Epidermal and dermal effects of epidermal growth factor during wound repair. J Invest Dermatol 1990; 94: 624-9. (Pubitemid 20141280)
9. Carter WG, Wayner EA, Bouchard TS, Kaur P,. The role of integrins alpha 2 beta 1 and alpha 3 beta 1 in cell-cell and cell-substrate adhesion of human epidermal cells. J Cell Biol 1990; 110: 1387-404.
10. Wysocki AB, Grinnell F,. Fibronectin profiles in normal and chronic wound fluid. Lab Invest 1990; 63: 825-31.
11. Bucalo B, Eaglstein WH, Falanga V,. Inhibition of cell proliferation by chronic wound fluid. Wound Rep Regen 1993; 1: 181-6.
12. Tanaka E, Ase K, Okuda T, Okumura M, Nogimori K,. Mechanism of acceleration of wound healing by basic fibroblast growth factor in genetically diabetic mice. Biol Pharm Bull 1996; 19: 1141-8. (Pubitemid 26342254)
13. Okumura M, Okuda T, Okamoto T, Nakamura T, Yajima M,. Enhanced angiogenesis and granulation tissue formation by basic fibroblast growth factor in healing-impaired animals. Arzneimittelforschung 1996; 46: 1021-6. (Pubitemid 26353899)
14. Okumura M, Okuda T, Nakamura T, Yajima M,. Acceleration of wound healing in diabetic mice by basic fibroblast growth factor. Biol Pharm Bull 1996; 19: 530-5. (Pubitemid 26144609)
15. Ishibashi Y, Niimura M, Nishikawa T, Nakajima H, Mizoguchi M, Hori Y, Furue M,. Investigation on clinical usefulness of recombinant human type bFGF (KCB-1) toward various pressure ulcer. J Clin Therapeutics Med 1993; 9: 2553-70.
16. Ishibashi Y, Soeda S, Ohura T, Soeda S, Nishikawa T, Niimura M, Nakajima H, Mizoguchi M, Shioya N, Tsukada S, Hori Y, Ogawa N,. Evaluation of effect of recombinant human type bFGF (KCB-1) on pressure ulcer-The Phase III Clinical Trial Using Combination Drug of White Sugar/Povidone Iodine as Control Drug. J Clin Ther Med 1996; 12: 2159-82.
17. Soeda S, Ohura T, Shioya N, Tsukada S,. Investigation on usefulness of bFGF (KCB-1) toward various pressure ulcer-The Early Phase II Clinical Trial Using 0.05% Solution. Jpn J Clin Exp Med 1993; 70: 2660-74.
18. Ohura T, Sugawara T, Hasaki T, Imai H, Amano F, Chiba Y,. New assessment table of pressure ulcer from a view point of wound healing-comparison with PSST/evaluation (Ohura). Jpn J Press Ulcers 2000; 2: 275-94.
19. Ohura T,. Risk factors for pressure ulcers in bedridden elderly persons-verification of the importance of pressure relief mattress. Jpn J Press Ulcers 2003; 5: 459-71.
20. Health and Welfare for Elderly, Ministry of Health, Labour and Welfare. Notice of the director No. 102-2, Assessment criterion for activity of daily life, 2006.
21. Littell RC, Milliken GA, Stroup WW, et al. SAS System for Mixed Models. Chapter 3 Analysis of Repeated Measures Data. 87-134. Cary, NC: SAS Institute Inc, 1996.
22. Fujiwara O, Soejima K, Nozaki M, Masuda M, Sakurai H,. Treatment of acute second degree burn wound with bFGF. Jpn J Burn Inj 2008; 34: 71-8.
23. Akita S, Akino K, Imaizumi T, Hirano A,. A basic fibroblast growth factor improved the quality of skin grafting in burn patients. Burns 2005; 31: 855-8. (Pubitemid 41394142)
24. Shiozawa K, Mukae N, Nishimura G,. Inhibition of hypertrophic scars by administration of basic fibroblast growth factor. Jpn J Plast Surg 2008; 52: 543-9.
25. Uchi H, Igarashi A, Urabe K, Koga T, Nakayama J, Kawamori R, Tamaki K, Hirakata H, Ohura T, Furue M,. Clinical efficacy of basic fibroblast growth factor (bFGF) for diabetic ulcer. Eur J Dermatol 2009; 19: 461-8.
26. Ohura T, Aso Y, Kondo K, Sanada H, Shido K, Sugiyama M, Tokunaga K, Nishimura A, Fujii T, Maekawa A, Miyaji Y, Murayama S, Moriguchi T,. Pressure ulcer risk factor and comprehensible guideline of prevention/medical treatment of pressure ulcer. Jpn Medical J 2001; 4037: 19-29.
27. Ohura T,. Pressure ulcer risk factor in elderly people. Jpn J Press Ulcers 2002; 4: 397-405.
28. Ohura T, editor. The causes of pressure ulcer (pressure, shear force and morbid bony prominence). In: Comprehensible guide of prevention/medical treatment of pressure ulcer. Tokyo: Syourin Co, Ltd, 2001: 28-55.
29. Bennett L, Kavner D, Lee BK, Trainor FA,. Shear vs pressure as causative factors in skin blood flow occlusion. Arch Phys Med Rehabil 1979; 60: 309-14. (Pubitemid 9220923)
30. Daniel RK, Priest DL, Wheatley DC,. Etiologic factors in pressure sores: an experimental model. Arch Phys Med Rehabil 1981; 62: 492-8. (Pubitemid 11017128)
31. Ohura T, Ohura N Jr, Oka H,. Incidence and clinical symptoms of hourglass and sandwich shaped tissue necrosis in stage IV pressure ulcers. Wounds 2007; 19: 310-9.
32. Sachse RE, Fink SA, Klitzman B,. Multimodality evaluation of pressure relief surfaces. Plast Reconstr Surg 1998; 102: 2381-7. (Pubitemid 29003558)
33. Ohura T, Takahashi M, Ohura N Jr,. Influence of external forces (pressure and shear force) on superficial layer and subcutis of porcine skin and effects of dressing materials: are dressing materials beneficial for reducing pressure and shear force in tissues? Wound Rep Regen 2008; 16: 102-7.
34. Linder-Ganz E, Shabshin N, Itzchak Y, Gefen A,. Assessment of mechanical conditions in sub-dermal tissues during sitting: a combined experimental-MRI and finite element approach. J Biomech 2007; 40: 1443-54. (Pubitemid 46601441)
35. Okuno T, Haga T, Kume H, Yoshizawa T,. Multivariate analysis method (Revised version) III, primary component analysis. Tokyo: Japanese Union of Scientists and Engineers, 1981: pp. 159-258.